Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- GMA-012 - Provider product page
- Provider
- Green Mountain Antibodies
- Product name
- Anti-Factor VIII
- Antibody type
- Monoclonal
- Antigen
- Factor VIII
- Description
- GMA-012 is a versatile A2 domain specific antibody useful for detection of Factor VIII by western blot, ELISA, and immunoprecipitation. It is also used for affinity purification of Factor VIII from plasma. GMA-012 is frequently cited in literature under the name of R8B12. It pairs well with all of the 8000 series GMA antibodies (with the best pairing with GMA-8016 for sandwich ELISA). Wakabayashi, H et al. describes a sandwich ELISA of GMA-012 with GMA-8002 in reference 7.
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- GMA-012
- Vial size
- 0.1mg, 0.5mg
Submitted references Activated factor X cleaves factor VIII at arginine 562, limiting its cofactor efficiency.
Factor VIII lacking the C2 domain retains cofactor activity in vitro.
Enhanced factor VIII heavy chain for gene therapy of hemophilia A.
Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12.
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII.
Revision of the International Health Regulations. Progress Report, July 1997.
Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations 1997 Jul 18;72(29):213-5
Plantier JL, Rolli V, Ducasse C, Dargaud Y, Enjolras N, Boukerche H, Négrier C
Journal of thrombosis and haemostasis : JTH 2010 Feb;8(2):286-93
Journal of thrombosis and haemostasis : JTH 2010 Feb;8(2):286-93
Factor VIII lacking the C2 domain retains cofactor activity in vitro.
Wakabayashi H, Griffiths AE, Fay PJ
The Journal of biological chemistry 2010 Aug 13;285(33):25176-84
The Journal of biological chemistry 2010 Aug 13;285(33):25176-84
Enhanced factor VIII heavy chain for gene therapy of hemophilia A.
Chen L, Lu H, Wang J, Sarkar R, Yang X, Wang H, High KA, Xiao W
Molecular therapy : the journal of the American Society of Gene Therapy 2009 Mar;17(3):417-24
Molecular therapy : the journal of the American Society of Gene Therapy 2009 Mar;17(3):417-24
Epitope mapping factor VIII A2 domain by affinity-directed mass spectrometry: residues 497-510 and 584-593 comprise a discontinuous epitope for the monoclonal antibody R8B12.
Ansong C, Miles SM, Fay PJ
Journal of thrombosis and haemostasis : JTH 2006 Apr;4(4):842-7
Journal of thrombosis and haemostasis : JTH 2006 Apr;4(4):842-7
Phenotypic correction of a mouse model of hemophilia A using AAV2 vectors encoding the heavy and light chains of FVIII.
Scallan CD, Liu T, Parker AE, Patarroyo-White SL, Chen H, Jiang H, Vargas J, Nagy D, Powell SK, Wright JF, Sarkar R, Kazazian HH, McClelland A, Couto LB
Blood 2003 Dec 1;102(12):3919-26
Blood 2003 Dec 1;102(12):3919-26
Revision of the International Health Regulations. Progress Report, July 1997.
Releve epidemiologique hebdomadaire / Section d'hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record / Health Section of the Secretariat of the League of Nations 1997 Jul 18;72(29):213-5
No comments: Submit comment
No validations: Submit validation data